Vera Therapeutics, Inc. (VERA)
44.68
-0.35
(-0.78%)
USD |
NASDAQ |
Dec 09, 16:00
44.40
-0.28
(-0.63%)
After-Hours: 20:00
Vera Therapeutics EPS Diluted (Quarterly): -1.258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Insmed, Inc. | -1.747 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Krystal Biotech, Inc. | 2.660 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.29M |
| Total Expenses (Quarterly) | 80.29M |
| Enterprise Value | 2.459B |
| Earnings Yield | -8.93% |
| Normalized Earnings Yield | -8.927 |